Oxypertine in combination with imipramine: a controlled trial

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Trials

Background:

• Endogenous depression requires effective treatment strategies.
• Combination therapies are explored to enhance antidepressant efficacy.
• The potential interaction between imipramine and oxypertine warrants investigation.

Purpose of the Study:

• To assess the efficacy of oxypertine as an adjunct to imipramine in treating endogenous depression.
• To evaluate the safety and tolerability of combined imipramine and oxypertine therapy.
• To determine if oxypertine dose-ranging influences imipramine's therapeutic effect.

Main Methods:

• A controlled trial involving patients with endogenous depression.
• Patients received a therapeutic dose of imipramine in Week 1.
• Dose-ranging of oxypertine (30 mg, 60 mg daily) or placebo from Week 2 to Week 6.

Main Results:

• The study did not confirm the reported enhancement of imipramine by oxypertine.
• No significant difference in treatment outcomes was observed between groups.
• Further analysis on safety and tolerability is pending.

Conclusions:

• Oxypertine does not appear to enhance the efficacy of imipramine for endogenous depression.
• The combination therapy was not found to be superior to imipramine alone in this trial.
• Further research may be needed to explore other adjunctive treatments.